Bleeding in Patients Undergoing CABG (Coronary Artery Bypass Graft) During Dual Antiplatelet Therapy

Medical University of Graz

Status: Terminated

Conditions: Acute Coronary Syndrome

Study type: Observational

Funder types: Other

Identifiers

NCT02030548

NIS003684

Details and patient eligibility

About

The aim of the study is to evaluate surgery-related bleeding and mortality in patients needing acute coronary artery bypass grafting with or without valve replacement during dual antiplatelet therapy with aspirin and a P2Y12 receptor blocker (Clopidogrel, Prasugrel, Ticagrelor)

Enrollment: 144 patients

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

consecutive patients undergoing acute CABG with or without valve replacement within 7 days after last intake of dual antiplatelet therapy

Exclusion criteria

concomitant oral anticoagulants dialysis surgery employing hypothermic cardiac arrest

Trial design

144 participants in 1 patient group

acute CABG

Description:

patients undergoing acute CABG with or without valve replacement during dual antiplatelet therapy